oxymatrine has been researched along with arginyl-glycyl-aspartic acid in 1 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 4,556 | 17 | 1,799 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Dai, G; Hou, Y; Ji, G; Liu, Y; Song, Z; Yang, J; Zhang, Y | 1 |
1 other study(ies) available for oxymatrine and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats.
Topics: Actins; Alkaloids; Animals; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Drug Carriers; Gene Expression; Hepatic Stellate Cells; Hydrophobic and Hydrophilic Interactions; Lactones; Liver; Liver Cirrhosis; Male; Maleimides; Nanostructures; Oligopeptides; Polyesters; Polyethylene Glycols; Quinolizines; Rats; Rats, Wistar | 2014 |